Key result
Factor V Leiden mutation was associated with a nonsignificant 2.11-fold increased risk of dementia compared to non-carriers, with no association found for APC response.
Why the study?
Does factor V Leiden mutation or activated protein C response increase the risk of dementia and its subtypes in adults aged 55 years or older?
Case-Control (n=701)
Does factor V Leiden mutation or activated protein C response increase the risk of dementia and its subtypes in adults aged 55 years or older?
Factor V Leiden mutation is associated with a significantly increased risk of vascular dementia, though the association with overall dementia was not statistically significant.
Answers are grounded in this paper and cite their sources.
Does not support Factor V Leiden testing for dementia risk; leaves open subtype-specific associations for prospective study.
We performed a cross-sectional case-control study among 295 subjects with dementia and 406 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, to evaluate the association of the factor V Leiden mutation and activated protein C (APC) response with dementia and its subtypes. The risk of dementia was 2.11-fold increased among carriers of factor V Leiden mutation relative to subjects lacking factor V Leiden mutation (95% confidence interval, CI, 0.93-4.77). The increased risks of vascular dementia and of Alzheimer's disease were 4.28 (95% CI 1.26-14.5) and 2.15 (95% CI 0.82-5.63), respectively. No association was found for APC response. We showed a nonsignificant twofold increased risk of dementia among subjects with factor V Leiden. The association appeared to be stronger for vascular dementia.
No takes yet. Share an insight, caveat, or question.
Bots et al. (1998) conducted a case-control in Dementia (n=701). Factor V Leiden mutation vs. Subjects lacking factor V Leiden mutation was evaluated on Dementia (OR 2.11, 95% CI 0.93-4.77). Factor V Leiden mutation was associated with a nonsignificant 2.11-fold increased risk of dementia compared to non-carriers, with no association found for APC response.
Synapse has enriched 10 related papers. Consider them for comparative context: